SCHEMBL7081986

SCHEMBL7081986

OC1C2CC3CC(C2)CC1(c1ccccc1Cl)C3

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 11/20 0.39
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
KDM1A O60341 1/20 0.34
HDAC4 P56524 1/20 0.34
CNR2 P34972 1/20 0.34
PTGS2 P35354 1/20 0.33
OPRK1 P41145 1/20 0.33
HSD11B1 P28845 1/20 0.32
HSD11B2 P80365 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7083692 0.80 SIGMAR1 (0.39) P2RX7HDAC4CNR2HSD11B1HSD11B2
SCHEMBL7079060 0.76 HDAC4 (0.38) GAASMN1; SMN2HDAC4HSD11B1
SCHEMBL7078036 0.76 HDAC4 (0.39) P2RX7HDAC4CNR2HSD11B1
SCHEMBL12760777 0.76 MEN1 (0.35) P2RX7NPC1LMNARAB9ANPSR1
SCHEMBL4607913 0.75 P2RX7 (0.40) P2RX7LMNAHTTNPSR1CNR2
SCHEMBL7079601 0.69 HSP90AA1 (0.33) P2RX7NPC1LMNAGAAHTT
SCHEMBL24626840 0.68 PDK2 (0.37) P2RX7HTTCNR2OPRK1
SCHEMBL27869456 0.66 HTT (0.43) P2RX7HTTSMN1; SMN2HSD11B1
SCHEMBL30688050 0.65 KDM1A (0.46) P2RX7KDM1AOPRK1HSD11B1
SCHEMBL30978073 0.65 MAPT (0.37) P2RX7NPC1GAAHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003064372-A1 2-ADAMANTYLALKYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION VERNALIS RESEARCH LIMITED (GB) 2003-08-07 WO disclosed